Welcome to our dedicated page for Constellium Se SEC filings (Ticker: CSTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Constellium SE (NYSE: CSTM) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As an NYSE‑listed issuer of ordinary shares, Constellium submits periodic and current reports that describe its financial condition, segment performance, governance changes and other material events.
Among the most relevant documents for investors are current reports on Form 8‑K. Constellium uses Form 8‑K to announce results of operations and financial condition under Item 2.02, typically in connection with quarterly earnings releases and investor presentations. These filings reference detailed press releases and slide decks that include shipments, revenue, net income, Adjusted EBITDA, Segment Adjusted EBITDA for the Aerospace & Transportation (A&T), Packaging & Automotive Rolled Products (P&ARP) and Automotive Structures & Industry (AS&I) segments, as well as the impact of metal price lag.
Constellium also files 8‑Ks under Item 5.02 to disclose departures and appointments of directors and certain officers and related compensatory arrangements. For example, the company has reported the Board’s decision to appoint Ingrid Joerg as Chief Executive Officer and director, effective January 1, 2026, and has outlined the key terms of her employment agreement. The same filing describes the planned transition of Jean‑Marc Germain to a Special Advisor role and summarizes his transition agreement.
Over time, investors can also review annual reports on Form 10‑K and quarterly reports on Form 10‑Q (when available) to analyze Constellium’s consolidated financial statements, risk factors, segment information, discussion of metal price lag and explanations of trends in its aerospace, packaging, automotive and industrial businesses. Forms 3, 4 and 5, when filed, provide data on insider holdings and changes in ownership by directors and officers.
Stock Titan enhances these filings with AI-powered summaries that explain key points in plain language, highlight important changes from prior periods and draw attention to items such as segment performance, leverage metrics, share repurchases, leadership changes and compensation arrangements. Real-time updates from EDGAR help ensure that new CSTM filings, including 10‑K, 10‑Q, 8‑K and insider transaction reports, appear promptly so users can review the underlying documents and AI insights in one place.
Constellium SE has filed a preliminary Proxy Statement for its 2026 Annual General Meeting to be held on May 21, 2026. The Board asks shareholders to vote on sixteen resolutions including ratification and re-appointment of directors, advisory votes on executive compensation frequency, approval of statutory and consolidated financial statements, discharge of directors, authorization for share repurchases under French law, and increases to the aggregate cap on directors’ annual fixed fees. The statutory accounts show a Company net loss of €7,184,045.19 and the Group consolidated net income of $257 million for the year ended December 31, 2025. The Proxy Statement will be first made available on or about April 10, 2026, with U.S. and French record dates of April 1, 2026 and May 13, 2026, respectively.
Constellium SE senior vice president and chief procurement officer Marcus Becker sold 10,000 ordinary shares in an open-market transaction. The shares were sold at a weighted average price of $25.09 per share, with individual trade prices ranging from $25.08 to $25.11. Following this sale, he continues to directly own 27,175 ordinary shares of Constellium SE.
CONSTELLIUM SE director Jean-Christophe Deslarzes bought 1,665 ordinary shares in the open market. The purchase took place on March 2, 2026 at a price of $24.77 per share. After this transaction, he directly owns 40,700 ordinary shares of Constelium.
Constellium SE reports Rule 144 transactions in Common Stock: a sale of 15,570 shares on 02/20/2026 for $398,269.75 and a sale of 1,113 shares on 03/10/2026 for $28,796.79. The filing also lists RSU and PSU issuances of 6,912 and 14,592 shares respectively, dated 03/13/2026.
CONSTELLIUM SE reported that SVP GC & Secretary Stephen Charles Walters received a grant or award of 5,834 ordinary shares on 2026-03-12. Following this acquisition, he directly owns a total of 25,068 ordinary shares.
Weiler Wiebke reported acquisition or exercise transactions in this Form 4 filing.
CONSTELLIUM SE director Wiebke Weiler received an equity grant tied to future service. The filing reports an award of 625 ordinary-share-based restricted stock units, which vest in full on March 12, 2029, subject to the director’s continued employment. Following this grant, Weiler’s reported direct holdings total 625 shares.
Brun Nicolas reported acquisition or exercise transactions in this Form 4 filing.
CONSTELLIUM SE senior vice president Nicolas Brun reported an equity compensation award rather than a market purchase. He received 4,376 ordinary shares in the form of restricted stock units that were granted at no cash cost. These units vest in full on March 12, 2029, subject to his continued employment. Following this award, he is shown as holding 131,552 ordinary shares directly.
Jurkovic Philip Ryan reported acquisition or exercise transactions in this Form 4 filing.
Constellium SE senior vice president and CHRO Philip Ryan Jurkovic received a grant of 10,210 restricted stock units representing ordinary shares as executive compensation. The award was reported at a price of zero per share and increases his direct holdings to 220,933 ordinary shares.
The restricted stock units vest in full on March 12, 2029, subject to his continued employment, meaning he must remain with the company until that date to receive the underlying shares.
CONSTELLIUM SE senior vice president Ludovic Piquier reported an acquisition of 5,469 ordinary shares through a grant of restricted stock units. The units were granted at no cash cost and will vest in full on March 12, 2029, conditioned on his continued employment.
Following this equity award, Piquier directly holds 242,713 ordinary shares. This filing reflects a compensation-related stock grant rather than an open-market purchase or sale, increasing his long-term ownership stake in the company.
Becker Marcus reported acquisition or exercise transactions in this Form 4 filing.
Constellium SE reported that senior vice president and chief procurement officer Marcus Becker received a grant of 3,938 restricted stock units representing ordinary shares. These units were awarded at no cash cost and vest in full on March 12, 2029, subject to his continued employment. Following this compensation-related award, Becker directly owns 37,175 ordinary shares.